Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.40 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | PLAU | P00749 | 2/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10552187 | 1.00 | NR4A2 (0.41) | NR4A2ALDH1A1HPGDSMN1; SMN2MTNR1A | |
| SCHEMBL8972901 | 0.82 | MTNR1A (0.42) | NR4A2ALDH1A1HPGDSMN1; SMN2MTNR1A | |
| SCHEMBL9550507 | 0.79 | ERAP1 (0.47) | ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL23987343 | 0.78 | NR4A2 (0.40) | NR4A2ALDH1A1HPGDDHODH | |
| SCHEMBL9550421 | 0.78 | ERAP1 (0.41) | ALDH1A1HPGDDHODH | |
| SCHEMBL8949021 | 0.77 | NR4A2 (0.43) | NR4A2ALDH1A1HPGDSMN1; SMN2MTNR1A | |
| SCHEMBL8949014 | 0.77 | NR4A2 (0.43) | NR4A2ALDH1A1HPGDSMN1; SMN2MTNR1A | |
| SCHEMBL8949018 | 0.77 | NR4A2 (0.43) | NR4A2ALDH1A1HPGDSMN1; SMN2MTNR1A | |
| SCHEMBL9214778 | 0.76 | NR4A2 (0.44) | NR4A2ALDH1A1HPGDSMN1; SMN2MTNR1A | |
| SCHEMBL9550484 | 0.76 | MAOA (0.47) | ALDH1A1HPGDBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337672-A1 | METHOD OF CONTROLLING SOYBEAN RUST FUNGUS HAVING RESISTANCE TO QoI FUNGICIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-26 | — | — | US | disclosed |
| US-4877811-A | FUNGICIDES, INSECTICIDES, MITICIDES, PLANTH GROWTH REGULATORS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-10-31 | — | — | US | disclosed |
| EP-0267734-A2 | Chemical compounds | ZENECA LIMITED (GB) | 1988-05-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337672-A1 | METHOD OF CONTROLLING SOYBEAN RUST FUNGUS HAVING RESISTANCE TO QoI FUNGICIDE | CYC1, SQOR, MT-CO1 | NR4A2 2627/4885ALDH1A1 4422/4885HPGD 3137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.